Prevention Strategies of Malaria Controlling

First world countries would benefit from devoting so many resources to controlling the disease by developing a vaccine, which can help lower the chances of malaria re-emerging in the form of Plasmodium vivax. These practices will help limit not only infections of malaria, but also help researchers find strategies for limiting the spread of all insect-borne disease. Prevention Strategies for mosquito-related infections involve: Vaccinations to improve the immunity of people and new antimalarial medicine.

There are significant reasons for the re-emerging of malaria in Africa, Asia and Latin America. With the rapid spread of resistance of malaria parasites to chloroquine and the other quinolines, and the frequent armed conflicts in many countries, forcing large populations to settle under difficult conditions and sometimes in areas of high malaria transmission. These are some of the many significant reasons for the re-emerging of malaria. The present strategy for malaria control in Africa, adopted by the Ministerial Conference on Malaria in Amsterdam in 1992, is to prevent death, reduce illness, and decrease social and economic loss due to the disease. There are two main measures that are being taken to eliminate and reduce the incidence of infestation of malaria in Africa. First is medication for early treatment of the disease, management of severe and complicated cases, and prophylactic use on the most vulnerable population (most likely pregnant women). Second is the insecticide-treated nets for protection against mosquito bites. Each tool has its own problems in regard to field implementation.

Despite the lower risk of malaria infection in Asia compared to many African settings, the Greater Mekong Subregion faces significant challenges to maintain the successes achieved to date in malaria control and prevention. Resistance to artemisinin, which is the most effective treatment for malaria, poses a significant danger if not eliminated and could potentially lead to a surge in malaria cases. With the threat of resistance spreading in the region and beyond, Malaria Consortium plays a significant role, by working closely with national and international authorities and partners, to tackle this public health emergency.

Immunizations utilise vaccines to develop immunity and form a memory response to the pathogen bodies into thinking we have already had the disease. A vaccine contains a dead or weakened virus that our body can easily fight off. Memory cells are a type of B cell lymphocyte, that is able to remember a virus for next time the body is infected. Antibodies, also called immunoglobulins, are Y-shaped molecules that are proteins manufactured by the body to help fight against foreign substances called Antigens. Antigens are a substance, such as bacteria, viruses or fungi that can cause infection or disease and stimulate the immune system to produce antibodies.

Immunization can provide a greater benefit, if a sufficient number of people get vaccinated to help stop the spread of bacteria and viruses that cause diseases. Individuals who have AIDS, cancer or are transplant patients have a higher risk of contracting a severe disease, as they have immunocompromised or weakened immune systems. This can differ depending on each person’s degree of immune suppression. Prevention of various diseases for these individuals would be higher if they wash their hands, avoid touching farm animals and take extra care when travelling. Resistance to the spread of contagious diseases within a population that result if a sufficiently high proportion of individuals are immune to the disease, through vaccination. This is known as “Herd Immunity” or “community immunity”. For herd immunity to become affective the proportion of the population that has to be immune to interrupt disease transmission differs for each vaccine preventable disease but is around 90 per cent for most diseases. This then emphasises the need to stay vigilant and ensure high coverage rates are achieved, not only at the national level, but also at the local level.

The benefits towards child vaccination doesn’t just protect your child from diseases to also helps to prevent the spread of the disease. Vaccinating a child, at a young age reduces the risks that can pass on deadly diseases to another child or baby who hasn’t been vaccinated, this is why herd immunity is highly important. There are many risks to not immunizing yourself and your children, it makes you vulnerable to diseases such as, smallpox, chickenpox and Whooping cough diseases that are otherwise eradicated. For the first months of your baby’s life they have some protection from specific infections, only if the mother has had the disease or been immunised. This is known as passive immunity and occurs when antibodies are transferred from mother to baby during the nine months of pregnancy. The antibodies transmitted into the baby can be low and wears off quickly, this can put them at risk of diseases that can be prevented with vaccination. Health risks of immunizing come with effects from the vaccine are generally mild and temporary, such as pain, redness and swelling at the injection site and a low-grade fever. Serious reactions such as severe allergic reactions are extremely rare. There are many myths for Anti-vaccinate with the health risks saying that “If you vaccinate your child they could develop autism, SIDS, asthma and allergies”. These claims are not based in evidence as there is no linking cause to vaccines causing autism and the MMR Controversy. 10 studies involving over 1. 25 million children to determine if a relationship between autism spectrum disorders (ASDs) and vaccines, MMR vaccine, thimerosal or mercury existed. These 10 individual studies had not found relationships between MMR, mercury or thimerosal, and ASD. The relative risk (RR) of a child receiving an ASD diagnosis at ages 2 years, 3 years or 4 years based on whether the child had received 0 or 1 dose of MMR vaccine, whether the child had a sibling with ASD or a sibling without ASD. There is no association between MMR vaccination and increased ASD risk and no evidence that receipt of 1 or 2 doses of MMR vaccine was association with a raised risk of ASD for children with had an older sibling with ASD.

There are also alternatives for vaccinations. For instances you could breastfeed instead, there are many benefits towards this natural alternative as a mother passes her immunity to her baby, this then helps protect the infant from a number of diseases that formula babies are not protected from. There are recent studies that show that if a mother naturally builds up her immunity her antibodies can protect her and her baby against diseases and can be protected four times longer, then those mums who were vaccinated. By not vaccinating yourself and your children there will not only be health implications but financial and legal implications as well.